SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-03-009392
Filing Date
2003-08-13
Accepted
2003-08-13 17:01:10
Documents
9
Period of Report
2003-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y89178e10vq.txt 10-Q 148941
3 DISTRIBUTION AGREEMENT y89178exv10w1.txt EX-10.1 71917
4 AMENDMENT NO.1 TO DISTRIBUTION AGREEMENT y89178exv10w2.txt EX-10.2 5386
5 AMENDMENT NO.2 TO DISTRIBUTION AGREEMENT y89178exv10w3.txt EX-10.3 3618
6 AMENDMENT NO.3 TO DISTRIBUTION AGREEMENT y89178exv10w4.txt EX-10.4 3352
7 302 CERTIFICATION: CEO y89178exv31w1.txt EX-31.1 3464
8 302 CERTIFICATION: CFO y89178exv31w2.txt EX-31.2 3493
9 906 CERTIFICATION: CEO y89178exv32w1.txt EX-32.1 1323
10 906 CERTIFICATION: CFO y89178exv32w2.txt EX-32.2 1363
  Complete submission text file 0000950123-03-009392.txt   245559
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

IRS No.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 03842193
SIC: 2835 In Vitro & In Vivo Diagnostic Substances